4. Chemistry: analytical and immunological testing
  5. Biospecific ligand binding assay

CBIO Limited

Corporate Assignee

Rate now
  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Corporate Assignee

active

No affiliations

Chaperonin 10 immunosuppression

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chaperonin 10 immunosuppression

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Chaperonin 10 modulation of toll-like receptor-inducible...

Chemistry: analytical and immunological testing – Biospecific ligand binding assay
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Modified chaperonin 10

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

CBIO Limited does not yet have a rating. At this time, there are no reviews or comments for this inventor.

If you have personal experience with CBIO Limited, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CBIO Limited will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-P-2280770

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.

Canada

 Charities
 Companies
 MP Candidates
 Patents
 Employee Salary Disclosure

World

 Places of the World
 Scientific Papers

United States

 Banks
 Companies
 Counties
 Patents
 Employee Salary Disclosure